InVivoMAb Anti-Human EGFRvIII Antibody (Iv0218) from ProteoGenix; catalogue ARO-A13021; research use only.
Know who made it. See the evidence. Buy through one marketplace.
InVivoMAb Anti-Human EGFRvIII Antibody (Iv0218) is a ProteoGenix primary antibody supplied under catalogue number ARO-A13021 for research use only.
Target: EGFR; Clonality: Monoclonal Antibody; Buffer: 0.01M PBS, pH 7.4.; Reactivity: Human.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
EGFR identifies epidermal growth factor receptor in Homo sapiens (Human). This target record connects NCBI Gene 1956, UniProtKB P00533 and related ABMIUM catalogue products.
Biological function: EGFR is a receptor tyrosine kinase that binds EGF-family ligands and converts extracellular growth signals into intracellular signalling responses. Ligand binding promotes receptor dimerisation and autophosphorylation, activating pathways that regulate cell proliferation, survival, differentiation and migration.
